Protagonist Therapeutics Inc
PTGX85.400USD
+1.200+1.43%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
5.29BMarket Cap
10.01P/E TTM
Protagonist Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
434.43M
624.05%
EPS(YoY)
4.47
421.34%
Analyst Rating
BUY
2025-11-21
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its total revenue reached 434.43M, with a year-on-year change of 624.05%.
What is the Earnings Per Share (EPS) of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was 4.470, with a year-on-year change of 421.34%.
What is the net income of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its net income was 275.19M, with a year-on-year change of 448.54%.
What is the net margin of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its net profit margin was 63.34%, with a year-on-year change of 148.14%.
What is the gross margin of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was 54.39%, with a year-on-year change of 290.21%.
What is the Return on Assets (ROA) of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was 49.91%, with a year-on-year change of 291.51%.
What is the operating profit of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its operating profit was 252.84M, with a year-on-year change of 369.98%.
What are the current assets of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its current assets were 591.64M, with a year-on-year change of 66.39%.
What are the total assets of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its total assets of Protagonist Therapeutics Inc were 744.73M, with a year-on-year change of 108.05%.
What are the total liabilities of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its total liabilities of Protagonist Therapeutics Inc were 69.43M, with a year-on-year change of 226.36%.
What is the total equity of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its total equity of Protagonist Therapeutics Inc was 675.29M, with a year-on-year change of 100.58%.
What is the net operating income of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its net operating income of Protagonist Therapeutics Inc was 275.19M, with a year-on-year change of 448.54%.
What is the net investment of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its net investment of Protagonist Therapeutics Inc was -299.48M, with a year-on-year change of -662.86%.
What is the net financing of Protagonist Therapeutics Inc?
According to Protagonist Therapeutics Inc's FY2024 earnings report, its net financing of Protagonist Therapeutics Inc was 25.85M, with a year-on-year change of -84.83%.
